Metabolic Syndrome

Section 1: Introduction to Metabolic Syndrome<br>1. Beyond the Metabolic Syndrome: Adverse Lifelong Influences Emanating From Insulin Resistance On The Aging Process In Non-Diabetics<br>2. Metabolic syndrome- is it a disease or a risk factor for other disorders?<br>3. Intrauterine malnutrition and future risk of Metabolic Syndrome<br>4. Intervening at the stage of metabolic syndrome to prevent type 2 diabetes- is it justified?<br>5. Dietary fats and Metabolic Syndrome: How strong is the association?<br>6. Metabolic Syndrome needs treatment but with lifestyle interventions alone<br><br>Section 2: Epidemiology of Metabolic Syndrome<br>7. Epidemiology of Metabolic Syndrome: Global Scenario<br>8. Epidemiology of Metabolic Syndrome in South and South East Asians<br>9. Barker's Hypothesis and Metabolic Syndrome<br>10. Metabolic syndrome in Australian aborigines<br><br>Section 3: Pathogenesis and pathophysiology of Metabolic Syndrome<br>11. Diet in the pathogenesis of metabolic syndrome: Role of Sugar, salt and fat<br>12. Vitamin D deficiency and metabolic syndrome – Is there a causality?<br>13. Role of inflammation in the pathogenesis of Metabolic Syndrome<br>14. Role of oxidative stress in the pathogenesis of Metabolic Syndrome<br>15. Mitochondrial dysfunction and Metabolic syndrome<br>16. The entero-insular axis and metabolic syndrome<br>17. Type I interferons in metabolic syndrome<br>18. Immunometabolism, an emerging subspecialty of Metabolic Syndrome<br>19. Pathophysiology of metabolic syndrome: current concepts<br>20. Role of Circadian rhythms in Metabolic Syndrome<br>21. Ectopic fat distribution and its role in Metabolic Syndrome<br>22. The role of genetic and epigenetic factors in familial clustering of metabolic syndrome<br>23. High carbohydrate diet in the pathogenesis of Metabolic Syndrome<br>24. Endocrine disruptors in the pathogenesis of metabolic syndrome<br>25. Autoimmunity and Metabolic Syndrome<br><br>Section 4: Metabolic Syndrome – multisystemic manifestation<br>26. The burden of atherosclerotic cardiovascular disease in metabolic syndrome<br>27. Mechanisms of atherosclerosis in metabolic syndrome<br>28. NAFLD, the hepatic manifestation of metabolic syndrome<br>29. Obesity associated hypogonadism - a growing concern in metabolic syndrome<br>30. Sleep apnea – A cause or a consequence of Metabolic Syndrome?<br>31. The metabolic syndrome in psychiatry<br>32. Renal manifestations of Metabolic Syndrome: The link between obesity and chronic kidney disease<br>33. Unraveling neuropathic manifestations of metabolic syndrome: role of corneal confocal microscopy<br>34. Metabolic Syndrome and Periodontitis: pathophysiologic links and clinical implications<br>35. Metabolic Syndrome and Bone Health<br>36. Insulin resistance and the risk of Osteoporosis<br>37. Glucagon and Metabolic Syndrome<br><br>Section 5: Clinical assessment of Metabolic Syndrome<br>38. Measures of adiposity– from BMI to Waist circumference to neck circumference to body fat<br>39. The Role of Prediabetes in the Metabolic Syndrome<br>40. Assessment of insulin resistance: from the bench to bedside<br><br>Section 6: Management of Metabolic Syndrome<br>41. Dietary interventions to combat obesity and Metabolic Syndrome<br>42. Role of precision diet and intermittent fasting in the management of metabolic syndrome<br>43. Nutritional and Cognitive interventions to reduce cardiovascular risk in Metabolc Syndrome<br>44. Role of exercise in the prevention and management of Metabolic Syndrome<br>45. Should Vitamin D be used to treat Metabolic Syndrome?<br>46. Pharmacologic therapies in Metabolic syndrome with special reference to NAFLD<br>47. Role of newer anti-diabetes drugs in prediabetes: A systematic review<br>48. Management of Insulin resistance in PCOS<br>49. The role of bariatric surgery in the management of metabolic syndrome<br>50. Anti-inflammatory interventions to mitigate cardiovascular risk in metabolic syndrome<br>51. Management of new onset dysglycemia in transplant recipients<br>52. Prevention of Type 2 diabetes in Metabolic Syndrome: Role of the geneticist<br>53. Managing Metabolic Syndrome in a general practice setting<br>54. Dietary interventions to reduce cardiovascular risk in Metabolic Syndrome<br>55. Management of Lipid Abnormalities in Metabolic Syndrome<br><br>Section 7: Metabolic Syndrome in children and adolescents<br>56. Overview of metabolic syndrome in children and adolescents<br>57. Overview of metabolic syndrome in children and adolescents: Indian perspective<br>58. Metabolic syndrome in children and adolescents: Does ethnicity matter?<br>59. NAFLD in children and adolescents<br>60. PCOS in adolescents: Role of insulin resistance<br>61. The inter relationship between polycystic ovary syndrome (PCOS) and metabolic syndrome<br>62. Dietary interventions to improve cardiometabolic health outcomes in children and adolescents<br><br>Section 8: Metabolic Syndrome: Controversies to consensus<br>63. Metabolic Syndrome -are our definitiond fit for purpose?<br>64. Metabolic Syndrome: treat the whole or address each part?<br>65. Metabolic Syndrome and cancer risk<br><br>Section 9: Areas for future research<br>66. Assessment of abdominal obesity: to measure visceral fat, subcutaneous fat or both?<br>67. Obesity-mediated insulin resistance in target tissues: Role of adipokines, hepatokines and myokines<br>68. Can bariatric surgery cure metabolic syndrome?<br>69. Gut microbiota and metabolic syndrome: what’s new?<br>70. COVID19 and metabolic syndrome – an unholy alliance<br>71. MicroRNA modulation in metabolic syndrome: a novel insight in cardiometabolic disease<br>72. Role of artificial intelligence in tackling the metabolic syndrome pandemic<br>73. Glucose handling by the brain and its impact on metabolic syndrome<br>74. Impact of Hypoglycemia on cardiovascular risk in metabolic syndrome<br>75. Dietary interventions to combat obesity in metabolic syndrome- role of time restricted eating